Table 1 The Correlation between TAMs-associated TMSB10 expression and clinicopathological characteristics of lung adenocarcinoma
Variables | All, N (%) | TAMs-associated TMSB10 expression | P | |
|---|---|---|---|---|
Low, N (%) | Hihg, N (%) | |||
Age, mean ± SD | 63.0 ± 9.9 | 59.2 ± 8.1 | 64.7 ± 10.1 | < 0.001 |
< 65 | 102 (55.4) | 43 (75.4) | 59 (46.5) | < 0.001 |
≥ 65 | 82 (44.6) | 14 (24.6)) | 68 (53.5) | |
Gender | ||||
Male | 102 (55.4) | 30 (51.7) | 72 (57.1) | 0.608 |
Female | 82 (44.6) | 28 (48.3) | 54 (42.9) | |
Smoking history | ||||
Smoker | 93 (50.5) | 29 (50.9) | 64 (50.4) | 0.952 |
Non-smoker | 91 (49.5) | 28 (49.1) | 63 (49.6) | |
Tumor site | ||||
Upper or middle | 126 (68.5) | 40 (70.2) | 86 (67.7) | 0.740 |
Lower | 58 (31.5) | 17 (29.8) | 41 (32.0) | |
Tumor size | ||||
T1 + T2 | 158 (85.9) | 43 (75.4) | 115 (90.6) | 0.007 |
T3 + T4 | 26 (14.1) | 14 (24.6) | 12 (9.4) | |
Lymphatic metastasis | ||||
N0 | 114 (62.0) | 35 (60.3) | 79 (62.7) | 0.666 |
N1–N3 | 70 (38.0) | 23 (39.7) | 47 (37.3) | |
TNM stage | ||||
I + II | 118 (64.1) | 42 (73.7) | 76 (59.8) | 0.036 |
III | 66 (35.9) | 15 (26.3) | 51 (40.2) | |